3NT Medical
Single-use Steerable Endoscope for Sinus Surgery
Company Overview
Snapshot
Founded in February 2013 by Ehud Bendory and Eran Bendory, 3NT Medical operates with 11–50 employees. The company has raised $20.5 million across three funding rounds. In June 2020, 3NT Medical announced FDA clearance for its Colibri™ Endoscopy System.
Business overview
3NT Medical develops advanced medical devices for the Health Tech & Life Sciences sector, focusing on minimally invasive solutions for nasal disorders. Its core product, the Sinusway single-use steerable endoscope, provides enhanced access, visualization, and treatment capabilities for the farthest reaches of the nasal anatomy. The company aims to improve diagnosis and treatment across various care settings, serving markets within healthcare providers, hospitals, clinics, and diagnostics.
Strategic signal
In June 2020, 3NT Medical received FDA clearance for its Colibri™ Endoscopy System. This regulatory approval is a significant validation of the company's technology and opens the door for commercialization in the US market, signaling strong potential for growth and adoption within the medical device industry for minimally invasive sinus surgery.
Log in to access full profile ›Company Intelligence Q&A
- When was 3NT Medical founded?
- 3NT Medical was founded in February 2013 by Ehud Bendory and Eran Bendory.
- What is 3NT Medical's primary product?
- 3NT Medical's primary product is the Sinusway single-use steerable endoscope, designed for minimally invasive access, visualization, and treatment of the nasal anatomy.
- Has 3NT Medical received any regulatory clearances for its products?
- Yes, in June 2020, 3NT Medical announced FDA clearance for its Colibri™ Endoscopy System.
- Which investor participated in 3NT Medical's May 2018 funding round?
- In May 2018, Hoya Corporation invested in 3NT Medical during its C Round funding.
- What is the total capital raised by 3NT Medical?
- 3NT Medical has raised a total of $20.5 million across three funding rounds.